NCT03132155 - QUILT-3.031: AMG 337 in Subjects With Advanced or Metastatic Clear Cell Sarcoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 29, 2018

Primary Completion Date

August 13, 2021

Study Completion Date

September 21, 2021

Conditions

Clear Cell Sarcoma

Interventions

DRUG

AMG 337

6-{(1R)-1-\[8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)\[1,2,4\]triazolo\[4,3-a\]pyridin-3-yl\]ethyl}-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6H)-one•hydrate (1:1)

Trial Locations (2)

77030

The University of Texas, MD Anderson Cancer Center, Houston

90245

Chan Soon-Shiong Institute for Medicine, El Segundo